Precision microbiota therapy for IBD: premise and promise
Inflammatory Bowel Disease (IBD) is a spectrum of chronic inflammatory diseases of the intestine that includes subtypes of ulcerative colitis (UC) and Crohn’s Disease (CD) and currently has no cure. While IBD results from a complex interplay between genetic, environmental, and immunological factors,...
Saved in:
| Main Authors: | Manabu Nagayama, Lasha Gogokhia, Randy S. Longman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Gut Microbes |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/19490976.2025.2489067 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multiomics-Based Profiling of the Fecal Microbiome Reveals Potential Disease-Specific Signatures in Pediatric IBD (PIBD)
by: Anita H. DeSantis, et al.
Published: (2025-05-01) -
Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancer
by: Aonghus Lavelle, et al.
Published: (2022-12-01) -
Editorial: Current trends and future management of IBD, volume II
by: Sérgio Bronze, et al.
Published: (2025-06-01) -
Clinical Characteristics and Treatment of Middle-Aged and Elderly Patients with IBD in Shanghai, China
by: Mi L, et al.
Published: (2024-12-01) -
Malignancy and Inflammatory Bowel Disease (IBD): Incidence and Prevalence of Malignancy in Correlation to IBD Therapy and Disease Activity—A Retrospective Cohort Analysis over 5 Years
by: Agnieszka Jowita Kafel, et al.
Published: (2025-06-01)